American Association for Cancer Research
crc-22-0463-s03.pdf (697.32 kB)

Supplementary Figure S3 from Immunologic Assessment of Tumors from a Race-matched Military Cohort Identifies Mast Cell Depletion as a Marker of Prostate Cancer Progression

Download (697.32 kB)
journal contribution
posted on 2023-08-01, 14:20 authored by Cara C. Schafer, Jiji Jiang, Sally Elsamanoudi, Darryl Nousome, Denise Y. Young, Yingjie Song, Isabell A. Sesterhenn, Gregory T. Chesnut, Shyh-Han Tan

Supplementary Figure S3 shows non-significant relative cell type scores by BCR status.


DOD | USA | MEDCOM | CDMRP | DOD Prostate Cancer Research Program (PCRP)

DOD | Uniformed Services University of the Health Sciences (USU)



Our findings demonstrate that there are immune-related genes and pathways that differ by race. Impaired intratumoral cellular immune composition, especially for TIL-normalized mast cells, may be vital in predicting and contributing to prostate cancer disease progression.